Physical capacity measured with the 6MWT |
Process | The proportion of patients with COPD who underwent physical therapy treatment and who completed the 6MWT pre- and post-treatment to evaluate physical capacity | 60.7% | 26.1–88.8% |
Outcome | The mean change score ±95% CI of patients with COPD who underwent physical therapy treatment and pre- and post-treatment measurement with the 6MWT to evaluate physical capacity | 2.8 m | −5.4 to 13.4 |
Health-related quality of life measured with the CCQ |
Process | The proportion of patients with COPD who underwent physical therapy treatment and who completed the CCQ pre- and post-treatment to evaluate aspects of health-related quality of life | 62.6% | 14.8–88.7% |
Outcome | The mean change score ±95% CI of patients with COPD who underwent physical therapy treatment and pre- and post-treatment measurement with the CCQ to evaluate health-related quality of life | –0.1 | 0.3 to –0.6 |
Quadriceps strength measured with the HDD |
Process | The proportion of patients with COPD who underwent physical therapy treatment and who completed the HHD pre- and post-treatment to evaluate quadriceps strength | 31.4% | 5.9–87.5% |
Outcome | The mean change score ±95% CI of patients with COPD who underwent physical therapy treatment and pre- and post-treatment measurement with the HHD to evaluate quadriceps strength | 7.5 Nm | 2.7–13.1 |
Baseline measures for the 6MWT, CCQ, accelerometer and patient characteristics that can be used in a profiling system to stratify patients into subgroups for care¶ |
Process | The proportion of patients with COPD who underwent physical therapy treatment and who completed the baseline measurements for the 6MWT, CCQ, accelerometer, gender, age, body weight and number of exacerbations in the past year | 2.4% | |